initial public offerings (IPOs) trading on American exchanges

Thursday, March 6, 2014

Inogen (INGN) began trading on the NASDAQ on 14 February 2014


Inogen, Inc. (Inogen) is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It offers Inogen One systems for the patients who require long-term oxygen therapy. The Company’s products include Inogen One G3 and Inogen One G2. The Inogen One G3 and Inogen One G2, weighs at approximately 4.8 and 7.0 pounds, respectively, are amongst the most lightweight portable oxygen concentrators. It markets its product offerings, the Inogen One G3 and the Inogen One G2, as single solutions for oxygen therapy. One G2 is effective for nocturnal use. Its Inogen One G2 and the Inogen One G3 are sub-5 and sub-10 pound portable oxygen.


326 Bollay Drive
GOLETA, CA 93117
United States 

Key stats and ratios

Q3 (Sep '13)2012
Net profit margin3.91%1.16%
Operating margin4.48%1.71%
EBITD margin-11.97%
Return on average assets5.32%1.57%
Return on average equity--

No comments:

Post a Comment